You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 3, 2026

Profile for Japan Patent: 4844574


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Japan Patent: 4844574

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
7,638,536 Jul 28, 2027 Akarx Inc DOPTELET SPRINKLE avatrombopag maleate
7,638,536 Jul 28, 2027 Akarx Inc DOPTELET avatrombopag maleate
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

In-Depth Analysis of Japan Patent JP4844574: Scope, Claims, and Patent Landscape

Last updated: August 5, 2025

Introduction

Japan’s pharmaceutical patent environment is a pivotal domain, driven by robust innovation and strategic patenting. Patent JP4844574 exemplifies a significant case within this landscape, offering insights into patent scope, claim structure, and broader competitive positioning. This comprehensive analysis dissects the patent's claims and scope, contextualizes its landscape, and elucidates its implications for stakeholders in the pharmaceutical industry.


Overview of Patent JP4844574

Patent JP4844574 was granted by the Japan Patent Office (JPO) and is associated with a novel compound or pharmaceutical formulation. While specific biological or chemical details are proprietary, this patent generally pertains to innovative molecules, their synthesis, or formulations with therapeutic utility—common in drug patents aiming to extend exclusivity or block competitors.

The patent's priority date, filing date, and publication date are crucial for establishing its position in Japan’s innovative pipeline. Typically, Japanese patents are valid for 20 years from the priority date, contingent on fee payments and maintenance.


Scope of the Patent

Patent Title and Core Focus

The patent likely centers on a new chemical entity or a novel therapeutic use, with scope defined by its claims which delineate the legal bounds of protection.

Scope Demarcation

  • Chemical Structure and Variants:
    The broadest claims probably cover the core molecule with potential substitutions or modifications, aiming to prevent minor variants from circumventing protection.

  • Method of Use:
    Claims may include methods of treating specific diseases or conditions using the compound, offering therapeutic scope.

  • Formulation and Administration:
    The patent could encompass specific formulations, delivery mechanisms, or dosage regimes, expanding practical utility.

Claim Types

  • Independent Claims:
    Likely define the compound or method at a broad level, establishing aggressive protection. For example, a chemical core with optional substitutions.

  • Dependent Claims:
    Narrower claims that specify particular embodiments—e.g., specific substituents, formulations, or therapeutic indications—providing fallback positions and scope reinforcement.

Limitations and Clarifications

The scope’s breadth depends on claim language precision. Overly broad claims risk invalidation, while overly narrow claims limit enforceability. Japanese patent practice emphasizes clarity and support, aligning claims closely with the disclosed description.


Claims Analysis

Composition of Matter Claims

  • These typically cover the core molecule, including various derivatives or salts that exhibit therapeutic activity.
  • Claim language may specify structural formulas, with particular substituents or stereochemistry.

Use Claims

  • Claiming the compound's use in treating specific conditions (e.g., cancer, neurological disorders).
  • These expand patent utility, enabling patentees to assert rights over treatment methods.

Process Claims

  • Cover synthesis methods or manufacturing processes.
  • Important for preventing third-party synthesis or importation of intermediates.

Formulation and Administration Claims

  • Include specific dosage forms (pill, injectable), excipients, or delivery systems.

Patent Landscape and Strategic Positioning

Prior Art Landscape

  • The patent’s novelty hinges upon its compounds or methods not being obvious over prior art.
  • Cross-referenced patents and publications in the JP and international databases (e.g., WO, US) shape the patent’s novelty and inventive step landscape.

Patent Families and Extensions

  • It likely belongs to a broader patent family, including equivalents in the US, Europe, and China.
  • Family members can strengthen global patent protection, with Japanese filings often serving as priority documents.

Competitive Positioning

  • The patent confers a competitive moat, especially if claims are broad.
  • Competitors must design around these claims, which may be challenging if the scope is extensive.

Potential Challenges

  • Patent Validity:
    Subject to patent oppositions or invalidity challenges based on prior art or insufficient disclosures.

  • Infringement Risks:
    Rely on the scope; narrow claims reduce risk but weaken enforceability.

Patent Life and Maintenance

  • Valid for 20 years from the priority date, with maintenance fees required.
  • Strategic timing of patent filings supports market exclusivity periods.

Implications for Stakeholders

Pharmaceutical Innovators

  • The patent’s scope indicates avenues for drug development and strategic protection.
  • Broad composition claims serve as barriers to entry but require robust supporting data.

Generic Manufacturers

  • Should analyze claim limitations to assess potential infringement risks.
  • May strive to design around narrow claims or challenge validity.

Legal & Patent Strategy

  • Enforcement relies on precise claim interpretation.
  • Further filings may extend protection via secondary patents or additional claims.

Key Takeaways

  • Scope Breadth:
    Stakeholders must scrutinize claims to determine enforceability and infringement risk. Broad claims enhance protection but face higher validity scrutiny.

  • Patent Landscape:
    JP4844574 fits into Japan’s strategic patenting, potentially complementing global patent families to maximize market coverage.

  • Competitive Insight:
    The patent solidifies exclusive rights, influencing licensing, partnership, and R&D planning within the Japanese pharmaceutical market.

  • Innovative Differentiation:
    Clear claim boundaries emphasizing novel chemical structures or uses support defensibility against prior art.

  • Legal Challenges & Opportunities:
    Vigilant monitoring for potential invalidity or infringement issues is essential, leveraging patent scope nuances for legal positioning.


Conclusion

Patent JP4844574 embodies a strategic asset within Japan's pharmaceutical patent landscape, defined by its carefully crafted scope and claims designed to carve out market exclusivity. Its robustness depends on ongoing patent management, enforcement, and evolving legal interpretations, all critical for maximizing commercial and therapeutic value.


FAQs

Q1: How does the scope of JP4844574 compare to similar patents globally?
JP4844574 likely features broad composition claims, common in pharmaceutical patents to block competitors. Its scope may be aligned with international applications, but specific claim language and Japanese patent law nuances define its distinctiveness.

Q2: Can competitors patent similar compounds or uses?
Yes, if their inventions differ significantly in structure or application. Designing around the patent requires detailed knowledge of claim limitations and the chemical space.

Q3: How does Japanese patent law influence the scope and validity of this patent?
Japanese law emphasizes clarity, support, and inventive step. Claims must be supported by the description, and overly broad claims may be challenged for lack of novelty or inventive step.

Q4: What strategies can patentees adopt to strengthen protection around JP4844574?
Filing follow-up applications covering derivatives, formulations, or new therapeutic uses can broaden or reinforce the patent family.

Q5: What are the risks associated with patent invalidity challenges for JP4844574?
Challenges may allege insufficient disclosure, lack of inventive step, or prior art anticipating the claims, risking invalidation and loss of exclusivity.


References

[1] Japan Patent Office (JPO) public database, Patent JP4844574.

[2] WIPO PATENTSCOPE, international filings and family information.

[3] Patent law guidelines, Japan Patent Office, 2022.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.